Dr Jacobson completed his PhD at UTas in 1996 in airways disease pharmacotherapy. He has worked in population health research (Menzies Centre for Population Health Research, now Menzies Research Institute), the pharmaceutical industry (Biometrics, Roche Products Pty Ltd) and commercial analytical laboratories.
Dr Jacobson commenced an academic appointment as Lecturer (Pharmaceutics) in the School in 2001.
Since this appointment Dr Jacobson has developed a new pharmaceutics research program within the School from the ground up with a strong emphasis on bio-analytical applications particularly in the areas of airways disease, antioxidants and natural product drug discovery.
Consultancies
In addition to research, Dr Jacobson actively undertakes a variety of pharmaceutical and biotechnology industry consultancies both with Australian and International clients.
Dr Jacobson's role as a consultant focuses on difficult and specialised bio-analytical applications and method development for novel drug delivery and biotechnology research. Areas of expertise include chiral assays and peptide analyses both from novel dosage forms and biological matrices. For new project enquiries, please contact Dr Jacobson via email.
Also see: http://www.ausbiotech.org/directory/details.asp?companyid={D81514B0-C301-41F8-9ADA-56DC9D2ED957}&returntourl=%2Fdirectory%2FalphabeticalIndex%2Easp
Research Interests
Dr Jacobsonšs research focus is clinical pharmaceutics including evidenced based natural product therapies and elucidation of active compounds.
Dr Jacobson research has a strong emphasis on bio-analytical applications, particularly chiral beta2-agonists, selenium and related antioxidants, protein and peptide therapeutics, utilising LC-MS, HPLC-DAD, HPLC-FD, ICP-MS, GC-MS and 2D proteomic methods.
Research Areas:Teaching
Pharmaceutical science
UnitsSelected Publications:- Jacobson GA, Yee KC, Ng CH, 2007, 'Elevated plsma glutathione peroxidase concentration in acute severe asthma: comparison with plasma glutathione peroxidase activity, selenium and malondialdehyde.', Scand J Clin Lab Invest, 67(4), pgs. 423-30
- Jacobson GA, Narkowicz C, Lord R, Howard BJ, Chung S, 2007, 'Effect of celecoxib on cyclooxygenase-2 expression and possible variants in a patient with Barrett's esophagus.', Dis Esophagus, 20(3), pgs. 265-8
- Jacobson GA, Tong YC, Townsend AT, Featherstone AM, Ball M, Robertson IK, Peterson GM, 2007, 'Selenium status in Southern Tasmania.', Eur J Clin Nutr, Jan 24; [Epub ahead of print]
- Cunningham CP, Brown JM, Jacobson GA, Brandon MR, Martinod SR, 2006, 'Evaluation of a covered-rod silicone implant containing ivermectin for long-term prevention of heartworm infection in dogs.', Am J Vet Res, Sep;67(9), pgs. 1564-9
- Jacobson GA, Narkowicz C, Tong YC, Peterson GM, 2006, 'Plasma glutathione peroxidase by ELISA and relationship to selenium level. 100-3. ', Clin Chim Acta, Jul 15;369(1), pgs. Epub 28 Feb 28 2006
- Jacobson GA, Martinod S, Cunningham CP, 2006, 'Determination of ceftiofur in bovine plasma by HPLC-DAD.
', J Pharm Biomed Anal, 40(5) - Epub 2005 Oct 19, pgs. 1249-52
- Jacobson GA, Chong FV, Davies NW, 2003, 'LC-MS method for the determination of albuterol enantiomers in human plasma using manual solid-phase extraction and a non-deuterated internal standard.
', J Pharm Biomed Anal, 31 (6), pgs. 1237-43
Full Publication List Current and Supervised Project/s:
|
